Clinical Trials
3 trialsNCT06980155 2025-05-20
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT06702566 2024-11-25
The Effect of Serum Ferritin in irAE
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting
NCT06536959 2024-08-05
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Beijing 302 Hospital
Phase 2 Recruiting